Trexquant Investment LP 4 D Molecular Therapeutics, Inc. Transaction History

Trexquant Investment LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$20.93 - $30.01 $594,098 - $851,833	28,385 New	28,385 $595,000
Q3 2023 Nov 13, 2023	BUY	$12.64 - $19.76 $561,759 - $878,193	44,443 New	44,443 $565,000
Q4 2022 Feb 13, 2023	SELL	$6.85 - $25.46 $45,162 - $167,857	-6,593 Reduced 26.25%	18,525 $411,000
Q3 2022 Nov 14, 2022	SELL	$6.96 - $11.48 $178,607 - $294,599	-25,662 Reduced 50.54%	25,118 $202,000
Q2 2022 Aug 11, 2022	BUY	$5.68 - $15.99 $288,430 - $811,972	50,780 New	50,780 $354,000

144

57.7M

137K

111K

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $272M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.